A. S. Majumdar

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella, Siddarth Reddy, William C. Blackwelder et al. · The Lancet · 2021 · 358 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

The monoclonal antibody TER‐119 recognizes a molecule associated with glycophorin A and specifically marks the late stages of murine erythroid lineage

Koichi Ikuta, Eiji Takayama, K. Wada et al. · British Journal of Haematology · 2000 · 350 citations

Mutations in SARS-CoV-2 viral RNA identified in Eastern India: Possible implications for the ongoing outbreak in India and impact on viral structure and host susceptibility

Arindam Maitra, Mamta Chawla‐Sarkar, Harsha Raheja et al. · Journal of Biosciences · 2020 · 150 citations · Full text

The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters

A. S. Majumdar, Douglas E. Hughes, Serge Lichtsteiner et al. · Gene Therapy · 2001 · 116 citations

Oncogenic Agent, Apoptosis, Cell Death +8

Amyloid Precursor Protein Regulates Differentiation of Human Neural Stem Cells

Young-Don Kwak, Christopher L. Brannen, Ting Qu et al. · Stem Cells and Development · 2006 · 96 citations